Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 54 (5) , 274-278
- https://doi.org/10.1016/s0753-3322(00)80071-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Asthma versus chronic obstructive pulmonary disease - exploring why ‘reversibility versus irreversibility’ is no longer an appropriate approachClinical and Experimental Allergy, 1999
- Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD)Clinical and Experimental Allergy, 1998
- The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthmaClinical and Experimental Allergy, 1997
- Mechanisms of human eosinophil survival and apoptosisClinical and Experimental Allergy, 1997
- Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitisClinical and Experimental Allergy, 1996
- Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid.Thorax, 1995
- Soluble markers of allergic inflammationAllergy, 1994
- Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 1993
- Quantitation of Mast Cells and Eosinophils in the Bronchial Mucosa of Symptomatic Atopic Asthmatics and Healthy Control Subjects Using ImmunohistochemistryAmerican Review of Respiratory Disease, 1990
- Neutrophil and Eosinophil Granulocytes in Bacterial Infection: Sequential Studies of Cellular and Serum Levels of Granule ProteinsBritish Journal of Haematology, 1978